Evidence map›Paper›PMID 18057139›Full record

ReviewEndocrine reviews2008

What can we learn from rodents about prolactin in humans?

Nira Ben-Jonathan, Christopher R LaPensee, Elizabeth W LaPensee

Open access · bronzeAbstract readReview
In one paragraph

Review in Endocrine reviews, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 192 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
192citing papers in PubMed, 2 pooled it
13.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

192 citing papers in PubMed, 2 syntheses or guidelines pooled it, 523 citations in OpenAlex.

  1. Prolactin and pain of endometriosis.Pharmacology & therapeutics · 2023
    Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Biphasic effects of moderate drinking on prolactin during lactation.Alcoholism, clinical and experimental research · 2008
    Trial
  6. Observational
  7. Article
  8. Stress, Well-Being, and Reproduction in Wildlife.Advances in experimental medicine and biology · 2026
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Effects of Prolactin Inhibition on Lipid Metabolism in Goats.Animals : an open access journal from MDPI · 2024
    Article
  16. Review
  17. Rat Models of Hormone Receptor-Positive Breast Cancer.Journal of mammary gland biology and neoplasia · 2024
    Review
  18. Current Insights in Prolactin Signaling and Ovulatory Function.International journal of molecular sciences · 2024
    Review
  19. Article
  20. Aberrant CD8Frontiers in immunology · 2024
    Article

132 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Nira Ben-JonathanDepartment of Cell and Cancer Biology, University of Cincinnati, Cincinnati, Ohio 45255, USA. Nira.Ben-Jonathan@uc.edu
Christopher R LaPensee
Elizabeth W LaPensee
University of Cincinnati · US

Funding

ENVIRONMETAL CARCINOGENESIS AND MUTAGENESIST32ES007250 · NIEHS · UNIVERSITY OF CINCINNATI · PI MILLER, WILLIAM E · 1988 to 2024
$11.9M
Training Program in Cancer TherapeuticsT32CA117846 · NCI · UNIVERSITY OF CINCINNATI · PI PRICE, CAROLYN M, TAKIAR, VINITA · 2006 to 2022
$6.5M
Prolactin as a Growth Factor in Breast CancerR01CA096613 · NCI · UNIVERSITY OF CINCINNATI · PI BEN-JONATHAN, NIRA · 2004 to 2013
$2.7M
GENETIC ANALYSIS OF MULTIDRUG RESISTANCE GENESZ01BC005725 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI DEAN, MICHAEL · 1996 to 2008
$1.9M
Xenoestrogens: Genomic and Non-genomic MechanismsR01ES012212 · NIEHS · UNIVERSITY OF CINCINNATI · PI BEN-JONATHAN, NIRA · 2003 to 2006
$1.1M
Intramural NIH HHS Z01 BC005725NCI NIH HHS CA096613NCI NIH HHS R01 CA096613NCI NIH HHS T32 CA117846NCI NIH HHS T32-CA 117846NIEHS NIH HHS ES012212NIEHS NIH HHS R01 ES012212NIEHS NIH HHS T32 ES007250NIEHS NIH HHS T32-ES 007250
6 · The paper itself

Abstract

Prolactin (PRL) is a 23-kDa protein hormone that binds to a single-span membrane receptor, a member of the cytokine receptor superfamily, and exerts its action via several interacting signaling pathways. PRL is a multifunctional hormone that affects multiple reproductive and metabolic functions and is also involved in tumorigenicity. In addition to being a classical pituitary hormone, PRL in humans is produced by many tissues throughout the body where it acts as a cytokine. The objective of this review is to compare and contrast multiple aspects of PRL, from structure to regulation, and from physiology to pathology in rats, mice, and humans. At each juncture, questions are raised whether, or to what extent, data from rodents are relevant to PRL homeostasis in humans. Most current knowledge on PRL has been obtained from studies with rats and, more recently, from the use of transgenic mice. Although this information is indispensable for understanding PRL in human health and disease, there is sufficient disparity in the control of the production, distribution, and physiological functions of PRL among these species to warrant careful and judicial extrapolation to humans.

Indexed as

Models, AnimalProlactinAnimalsFemaleGene Expression RegulationGrowthGrowth HormoneHumansMaleMammary Glands, AnimalMetabolismMicePituitary GlandPlacental LactogenPregnancyRatsGrowth HormonePlacental LactogenProlactinReceptors, Prolactin

Identifiers

PMID18057139
PMCPMC2244934
OpenAlexW2164875032

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.